|
Volumn 48, Issue 5, 2007, Pages 412-417
|
Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
CYCLOPEPTIDE;
IMMUNOSUPPRESSIVE AGENT;
LIPOPROTEIN;
MICAFUNGIN;
PYRIMIDINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
VORICONAZOLE;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
ASPERGILLOSIS;
CASE REPORT;
CORD BLOOD STEM CELL TRANSPLANTATION;
FATALITY;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG MYCOSIS;
MALE;
MIDDLE AGED;
MUCORMYCOSIS;
AMPHOTERICIN B;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
CORD BLOOD STEM CELL TRANSPLANTATION;
FATAL OUTCOME;
GRAFT VS HOST DISEASE;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
LEUKEMIA, MYELOCYTIC, ACUTE;
LIPOPROTEINS;
LUNG DISEASES, FUNGAL;
MALE;
MIDDLE AGED;
MUCORMYCOSIS;
PEPTIDES, CYCLIC;
PYRIMIDINES;
TRANSPLANTATION CONDITIONING;
TRIAZOLES;
|
EID: 34547130606
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|